The Effect of Cholesterol Oxidation Products on Human Platelet Aggregation
Overview
Authors
Affiliations
The cholesterol oxidation products (oxysterols) cholest-3,5-diene-7-one, cholestan-5 alpha, 6 alpha-epoxy-3 beta-ol (cholesterol 5 alpha-epoxide), cholestan-5 beta, 6 beta-epoxy-3 beta-ol (cholesterol 5 beta-epoxide), cholest-5-ene-3 beta-ol-7-one (7-ketocholesterol), cholest-5-ene-3 beta, 7 alpha-diol (7 alpha-hydroxycholesterol), cholestan-3 beta, 5 alpha, 6 beta-triol (cholestane triol), and cholest-5-ene-3 beta, 26-diol (27-hydroxycholesterol) potentiated platelet aggregation and increased thromboxane A2 formation in platelets challenged with thrombin, ADP or collagen. These effects were observed at oxysterol concentrations in the range 5-100 microM. Cholesterol 5 beta-epoxide and 7-ketocholesterol increased the mobilization of 3H-arachidonic acid from prelabelled platelet phospholipids in response to thrombin and collagen.
Oxysterols in catfish skin secretions (, Val.) exhibit anti-cancer properties.
Al-Hassan J, Afzal M, Oommen S, Liu Y, Pace-Asciak C Front Pharmacol. 2022; 13:1001067.
PMID: 36313377 PMC: 9614162. DOI: 10.3389/fphar.2022.1001067.
7-Ketocholesterol: Effects on viral infections and hypothetical contribution in COVID-19.
Ghzaiel I, Sassi K, Zarrouk A, Nury T, Ksila M, Leoni V J Steroid Biochem Mol Biol. 2021; 212:105939.
PMID: 34118414 PMC: 8188774. DOI: 10.1016/j.jsbmb.2021.105939.
Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated Platelets.
Unsworth A, Bye A, Tannetta D, Desborough M, Kriek N, Sage T Arterioscler Thromb Vasc Biol. 2017; 37(8):1482-1493.
PMID: 28619996 PMC: 5526435. DOI: 10.1161/ATVBAHA.117.309135.
Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins.
Florens N, Calzada C, Lyasko E, Juillard L, Soulage C Toxins (Basel). 2016; 8(12).
PMID: 27999257 PMC: 5198570. DOI: 10.3390/toxins8120376.
Cholesterol, reactive oxygen species, and the formation of biologically active mediators.
Murphy R, Johnson K J Biol Chem. 2008; 283(23):15521-5.
PMID: 18285330 PMC: 2414298. DOI: 10.1074/jbc.R700049200.